FDA Approves Panitumumab for Use in Wild-Type RAS Metastatic Colorectal Cancer – The ASCO Post

Panitumumab now approved for wild-type Ras metastatic colorectal cancer. Along with this, the FDA approved the first multigene, next-generation sequencing-based test to identify the RAS mutation status of a patient’s tumor tissue designed to help identify patients that are more likely to benefit from treatment with panitumumab. This highlights how important analysis of tumor tissue […]

Read More FDA Approves Panitumumab for Use in Wild-Type RAS Metastatic Colorectal Cancer – The ASCO Post

Louise auf Instagram: „SCAN RESULTS UPDATE……. TREATMENT IS WORKING 🙏🏻❤️🙏🏻❤️“

Dear blog readers, before the day ends we would like to share with you an encouraging update from Louise, one of our patients. Louise has been diagnosed with metastatic cervical carcinoma and has already been through lots of treatments. In 2017, she turned to us, as her tumor was spreading and growing further. At Hallwang, […]

Read More Louise auf Instagram: „SCAN RESULTS UPDATE……. TREATMENT IS WORKING 🙏🏻❤️🙏🏻❤️“